In this Webinar, discover:
- Subtle neurological deficits caused by TAVR
- Discrepancies between clinical presentation versus neurological imaging
- Stroke risk predictors, common misconceptions and the counterargument for cerebral embolic protection in low-risk patients
- Evolving economics of TAVR and changes to reimbursement
FEATURING:
David Z. Rose, MD
Neurology Medical Director
USF Health, Tampa, FL
Hemal Gada, MD
Cardiovascular Institute’s Structural Heart Program
UPMC Pinnacle, Harrisburg, PA
Full Replay

Watch by Chapter

TAVR-Related Stroke Risk Predictors

Why Subtle Neurological Deficits Matter

TAVR Costs in an Evolving Landscape

SENTINEL Technology and Clinical Data

The Economics of Stroke and Cerebral Embolic Protection